Intas Pharmaceuticals Deal History & Licensing Activity
Intas Pharmaceuticals is a life sciences. Over the past three years, Intas Pharmaceuticals has been involved in 1 licensing and acquisition transaction, with a primary focus on Antibodies (2 deals). The company currently has 1 active clinical trial, primarily in Immunology.
Deals (12mo)
1
Active Trials
1
Top Modality
Antibodies
Focus Area
Immunology
Intas Pharmaceuticals Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Intas Pharmaceuticals in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| BAT2506 | Bio-Thera Solutions | Antibodies | Unknown | license | Mar 2026 |
Intas Pharmaceuticals Pipeline Focus
Therapeutic areas and modalities where Intas Pharmaceuticals is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
Intas Pharmaceuticals Strategic Signals
Key indicators of Intas Pharmaceuticals's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
Intas Pharmaceuticals Clinical Pipeline
Intas Pharmaceuticals has 1 active clinical trial across 1 development phase.
1
Phase 3
See How Your Asset Matches Intas Pharmaceuticals's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Immunology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Immunology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for immunology
Antibodies Benchmarks
Upfront, milestone, and royalty benchmarks for antibodies deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Intas Pharmaceuticals Licensing & Deal Activity
Intas Pharmaceuticals is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Intas Pharmaceuticals ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Intas Pharmaceuticals include Immunology (2 deals and trials), and Solid Tumors (1 deal and trial). In terms of modality, Intas Pharmaceuticals has shown particular interest in antibodies.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Intas Pharmaceuticals and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Intas Pharmaceuticals's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.